The U.S. Food and Drug Administration (FDA) issued warning letters on May 20, 2026, to eight retailers for selling unauthorized tobacco products designed to resemble everyday consumer items such as candy, breath strips, and cough drops. The enforcement action targets nicotine pouches and dissolvable tobacco products that allegedly imitate common products through their labeling, advertising, and product design. According to the FDA, these products raise public health concerns because they may appeal to children and could be accidentally ingested by young children due to their resemblance to familiar household items. The agency stated that such marketing practices may also help conceal the true nature of tobacco products from parents, teachers, and other adults. The FDA directed the retailers to address the cited violations and warned that failure to comply could lead to additional enforcement actions, including seizures, injunctions, or civil monetary penalties. The action follows the FDA’s recently issued enforcement guidance regarding unauthorized electronic nicotine delivery systems (ENDS) and nicotine pouch products lacking premarket authorization.
Consult
